About This Study
The purpose of this study is to learn more about a new medicine called ravulizumab. We want to see if this medicine can help protect the kidneys of people with long-term kidney problems who are having open-heart surgery. The medicine may help prevent kidney damage caused by surgery. We will compare the medicine to a placebo to see if it works and is safe. Participants will be in this study for 90 days of follow-up.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 90 years old
- All Genders
Language
- This study enrolls English speakers only
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC